GLP-1 Access by StateCO

GLP-1 Weight Loss Medications in Colorado

Semaglutide and tirzepatide access in Colorado through telehealth, Health First Colorado, and Kaiser Permanente.

Telehealth Prescribing

Allowed

Restrictions

Colorado has progressive telehealth legislation (HB 19-1017 and subsequent updates). Providers must hold a Colorado license or participate in the Interstate Medical Licensure Compact. Telehealth parity is mandated for commercial insurance. No in-person visit is required before prescribing.

Prescribing Rules

GLP-1 medications can be prescribed via telehealth after a video consultation. Colorado does not impose additional requirements for non-controlled medication prescribing. The state allows advanced practice providers (NPs and PAs) to prescribe GLP-1s independently via telehealth.

Insurance Coverage

Medicaid Coverage

Yes (expanded)

Prior Authorization

Typically required

Major Insurers

Kaiser Permanente ColoradoAnthem Blue CrossCignaUnitedHealthcareDenver Health Medical Plan

Colorado expanded Medicaid (Health First Colorado) in 2014. Medicaid covers GLP-1s for type 2 diabetes. Colorado has been progressive in exploring anti-obesity medication coverage, and some Health First Colorado plans are beginning to cover GLP-1s for weight management with prior authorization. Colorado has one of the lowest adult obesity rates (24%) but growing demand for GLP-1s.

Cost Breakdown

Brand Name

$900-$1350

per month, without insurance

Compounded

Available

$175-$425

per month

Top Providers in Colorado

Kaiser Permanente Colorado

Both

Major integrated system along the Front Range with internal GLP-1 prescribing protocols.

UCHealth Weight Management

In-Person

University of Colorado Health system offers obesity medicine in Aurora and Fort Collins.

Found

Telehealth

Board-certified obesity medicine doctors serving Colorado residents via video visits.

Colorado Telehealth and GLP-1 Access

Colorado combines progressive telehealth legislation with a health-conscious population, creating strong demand for GLP-1 medications. The Front Range corridor (Fort Collins to Colorado Springs) has dense provider coverage, while mountain communities and the Western Slope rely heavily on telehealth. Colorado allows NPs and PAs to prescribe independently, expanding the pool of providers who can offer GLP-1 consultations through telehealth platforms.

Health First Colorado Medicaid Coverage

Health First Colorado (the state Medicaid program) covers GLP-1 receptor agonists for type 2 diabetes management. Colorado has been among the states exploring expanded coverage for anti-obesity indications. Prior authorization requires documented BMI, comorbidities, and evidence of lifestyle intervention. The state manages Medicaid through regional organizations, so specific GLP-1 coverage can vary by region.

Mountain Communities and Rural Access

Residents of mountain towns like Aspen, Telluride, Steamboat Springs, and Durango face limited local specialist availability. While local primary care providers can prescribe GLP-1s, telehealth connects these communities to board-certified obesity medicine specialists. Shipping compounded medications to mountain addresses is straightforward, though cold-chain considerations apply during summer months.

Telehealth bridges the gap for mountain and Western Slope communities
Denver/Boulder metro has the densest in-person provider network
Compounded semaglutide: $175-$425/month, available statewide

FAQ

Frequently Asked Questions

Kaiser Permanente Colorado covers GLP-1s for type 2 diabetes and has expanded weight management coverage. Patients typically need to complete Kaiser internal programs (nutrition counseling, lifestyle modifications) before GLP-1 approval.

Yes. Colorado grants NPs independent prescribing authority. Nurse practitioners can prescribe GLP-1 medications including Wegovy and Ozempic both in-person and via telehealth without physician supervision.

Yes. Colorado has strong telehealth parity laws. Non-controlled medications like semaglutide and tirzepatide can be prescribed via video consultation without an in-person visit.

Compounded semaglutide costs $175-$425/month through telehealth platforms and local compounding pharmacies. Brand-name Wegovy or Ozempic costs $900-$1,350/month without insurance.